
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
BrainXell focuses on neural cells for therapeutic development. Founded in 2015 by Prof. Su-Chun Zhang with help from the Discovery to Product (D2P) program of University of Wisconsin Madison, it is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons. BrainXell is developing drug discovery / toxicology testing platforms using patient-derived or genetically modified stem cells and provides large-scale production of highly enriched, functionally specialized neural cells to the pharmaceutical and biotechnology industry. BrainXell also aims to develop stem cell therapy for neurological injuries and diseases...
Induced pluripotent stem cells (ips cells),neurons,cortical neurons,gabaergic neurons,dopaminergic neurons,glutamatergic neurons,motor neurons,custom cells,neuronal differentiation,serotonergic neurons,glial cells,and astrocytes
Brainxell, inc operates in the Biotechnology research industry.
Brainxell, inc's revenue is 11m - 100m
Brainxell, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.